Pharmaceutical Quality by Design (QbD) is a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and control based on sound science and quality risk management.
Related Guidance Documents
Commissioning & Qualification (1)
Lifecycle Management (2)
Microbiological & Viral Contamination Control (1)
Process Analytical Technology (2)
Quality by Design (4)
Community Discussions
Community Discussions
Aug 18, 2023
Aug 16, 2023
Aug 15, 2023
Aug 14, 2023
Aug 09, 2023
Aug 08, 2023
Aug 07, 2023
Aug 02, 2023
Aug 02, 2023
Jul 24, 2023
Jul 19, 2023
Jul 05, 2023
Jul 05, 2023
Jul 01, 2023
Jun 26, 2023
Jun 21, 2023
Jun 20, 2023
Jun 15, 2023
Related Pharmaceutical Engineering Magazine Articles
ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma
ChatGPT and other large language models are positioned to change the world. They can also shift…
A Systemwide Approach to Managing the Risks of Continuous Manufacturing
Understanding and managing risks to continuous manufacturing (CM) technology is central to any…
Agile, Data-Driven Life Cycle Management for Continuous Manufacturing
Pharmaceutical continuous manufacturing (CM) is recognized as a key process intensification…
A Proposal for a Comprehensive Quality Overall Summary
When working with the common technical dossier (CTD), the structure of Module 2 “follows the scope…
ISPE Briefs: New Guide Promotes Cultural Excellence
Cultural excellence is the expressed and implied ways in which an organization operates. Excellence…
Why QbD and Digitalization Are Foundations for Cell Therapies
An interview with Shin Kawamata of Japan’s Foundation for Biomedical Research and Innovation (FBRI)…
Continuous Process: Implementing Low pH Viral Inactivation in a Continuous Process
Viral inactivation (VI) is a critical step in ensuring the safety of monoclonal antibody (mAb), Fc…
Material Properties Databases to Advance Pharmaceutical Processing
Pharmaceutical manufacturers rely heavily on powder processes, the majority of which are designed…
Biopharma Facility Design: Lessons Learned on the Dance Floor
In 2014, Pharmaceutical Engineering® published an article, “Lessons Learned in the Ballroom,”Wolton…
Justifying Investment in Manufacturing Execution Systems
Executives at manufacturing companies of all sizes need to make decisions about where to invest to…
Flexible Facility Design for Multiple Cell Therapy Processes
In many critical ways, the design of facilities for multiple cell therapy processes is unlike the…
Using CFD Multiphase Modeling to Predict Bioreactor Performance
Computational fluid dynamics (CFD) can reduce or eliminate the need to perform bioreactor scale-up…
